Non-ulcerating Calcific Uremic Arteriolopathy Skin Lesion Treated Successfully with Intravenous Ibandronate
Overview
Authors
Affiliations
Calciphylaxis in a Patient on Home Hemodialysis.
Adapa S, Naramala S, Gayam V, Koduri N, Daggubati S, Patel P J Investig Med High Impact Case Rep. 2020; 8:2324709620922718.
PMID: 32434389 PMC: 7243381. DOI: 10.1177/2324709620922718.
Treatment of Calciphylaxis in CKD: A Systematic Review and Meta-analysis.
Udomkarnjananun S, Kongnatthasate K, Praditpornsilpa K, Eiam-Ong S, Jaber B, Susantitaphong P Kidney Int Rep. 2019; 4(2):231-244.
PMID: 30775620 PMC: 6365410. DOI: 10.1016/j.ekir.2018.10.002.
Calciphylaxis: risk factors, diagnosis, and treatment.
Nigwekar S, Kroshinsky D, Nazarian R, Goverman J, Malhotra R, Jackson V Am J Kidney Dis. 2015; 66(1):133-46.
PMID: 25960299 PMC: 4696752. DOI: 10.1053/j.ajkd.2015.01.034.
Calcific uremic arteriolopathy: pathophysiology, reactive oxygen species and therapeutic approaches.
Sowers K, Hayden M Oxid Med Cell Longev. 2010; 3(2):109-21.
PMID: 20716935 PMC: 2952095. DOI: 10.4161/oxim.3.2.11354.
Calciphylaxis: calcific uremic arteriolopathy and the emerging role of sodium thiosulfate.
Hayden M, Goldsmith D, Sowers J, Khanna R Int Urol Nephrol. 2008; 40(2):443-51.
PMID: 18369733 DOI: 10.1007/s11255-008-9373-4.